Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Srinivas Bandaru

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Asian Pacific Journal of Cancer Prevention : APJCP|April 5, 2016
Pharmacological Analysis of Vorinostat Analogues as Potential Anti-tumor Agents Targeting Human Histone Deacetylases: an Epigenetic Treatment Stratagem for CancersSugathan Praseetha, Srinivas Bandaru, Anuraj Nayarisseri, et al.
Computational Biology and Chemistry|June 9, 2016
Design, synthesis and computational evaluation of a novel intermediate salt of N-cyclohexyl-N-(cyclohexylcarbamoyl)-4-(trifluoromethyl) benzamide as potential potassium channel blocker in epileptic paroxysmal seizuresV Natchimuthu, Srinivas Bandaru, Anuraj Nayarisseri, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 20, 2020
Intrinsic activation of cardiosphere-derived cells enhances myocardial repairToshikazu Sano, Tatsuo Ito, Shuta Ishigami, et al.
Current Pharmaceutical Design|June 25, 2016
Common SAR Derived from Multiple QSAR Models on Vorinostat Derivatives Targeting HDACs in Tumor TreatmentSugathan Praseetha, Srinivas Bandaru, Mukesh Yadav, et al.
Current Topics in Medicinal Chemistry|July 30, 2013
Binding modes and pharmacophoric features of muscarinic antagonism and β2 agonism (MABA) conjugatesSrinivas Bandaru, M Hema Prasad, A Jyothy, et al.
Bioinformation|October 1, 2015
Molecular Docking and Pharmacological Investigations of Rivastigmine-Fluoxetine and Coumarin-Tacrine hybrids against Acetyl Choline EsterasePallikkara Pulikkal Babitha, Mohammed Marunnan Sahila, Srinivas Bandaru, et al.
Inflammation|November 1, 2014
Association of transforming growth factor-Beta 1 promoter variant -509 c/t with bronchial asthma in South Indian populationSrinivas Bandaru, Vijaya Kumar Marri, Jyothy Akka, et al.
Bioinformation|December 10, 2014
Molecular docking analysis of RN18 and VEC5 in A3G-Vif inhibitionChanda Sinha, Anuradha Nischal, Kamlesh K Pant, et al.
Bioinformation|August 1, 2015
Molecular docking based screening of GABA (A) receptor inhibitors from plant derivativesMohammed Marunnan Sahila, Pallikkara Pulikkal Babitha, Srinivas Bandaru, et al.
Bioorganic Chemistry|November 25, 2024
In vitro evaluation of promiscuity and toxicity of a small molecule targeting wild and T164I β2-adrenergic receptorsSrinivas Bandaru, Someswar Rao Sagurthi, Arshiya Khan, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Asian Pacific Journal of Cancer Prevention : APJCP|April 5, 2016
Pharmacological Analysis of Vorinostat Analogues as Potential Anti-tumor Agents Targeting Human Histone Deacetylases: an Epigenetic Treatment Stratagem for CancersSugathan Praseetha, Srinivas Bandaru, Anuraj Nayarisseri, et al.
Computational Biology and Chemistry|June 9, 2016
Design, synthesis and computational evaluation of a novel intermediate salt of N-cyclohexyl-N-(cyclohexylcarbamoyl)-4-(trifluoromethyl) benzamide as potential potassium channel blocker in epileptic paroxysmal seizuresV Natchimuthu, Srinivas Bandaru, Anuraj Nayarisseri, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 20, 2020
Intrinsic activation of cardiosphere-derived cells enhances myocardial repairToshikazu Sano, Tatsuo Ito, Shuta Ishigami, et al.
Current Pharmaceutical Design|June 25, 2016
Common SAR Derived from Multiple QSAR Models on Vorinostat Derivatives Targeting HDACs in Tumor TreatmentSugathan Praseetha, Srinivas Bandaru, Mukesh Yadav, et al.
Current Topics in Medicinal Chemistry|July 30, 2013
Binding modes and pharmacophoric features of muscarinic antagonism and β2 agonism (MABA) conjugatesSrinivas Bandaru, M Hema Prasad, A Jyothy, et al.
Bioinformation|October 1, 2015
Molecular Docking and Pharmacological Investigations of Rivastigmine-Fluoxetine and Coumarin-Tacrine hybrids against Acetyl Choline EsterasePallikkara Pulikkal Babitha, Mohammed Marunnan Sahila, Srinivas Bandaru, et al.
Inflammation|November 1, 2014
Association of transforming growth factor-Beta 1 promoter variant -509 c/t with bronchial asthma in South Indian populationSrinivas Bandaru, Vijaya Kumar Marri, Jyothy Akka, et al.
Bioinformation|December 10, 2014
Molecular docking analysis of RN18 and VEC5 in A3G-Vif inhibitionChanda Sinha, Anuradha Nischal, Kamlesh K Pant, et al.
Bioinformation|August 1, 2015
Molecular docking based screening of GABA (A) receptor inhibitors from plant derivativesMohammed Marunnan Sahila, Pallikkara Pulikkal Babitha, Srinivas Bandaru, et al.
Bioorganic Chemistry|November 25, 2024
In vitro evaluation of promiscuity and toxicity of a small molecule targeting wild and T164I β2-adrenergic receptorsSrinivas Bandaru, Someswar Rao Sagurthi, Arshiya Khan, et al.
Pageof 5